Immune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has ...

Immune checkpoint inhibitors have transformed the management of advanced malignancies by releasing the brakes on antitumour T-cell responses. Agents targeting programmed cell death protein 1 (PD-1), ...

Despite remarkable advances in immunotherapy and targeted agents, therapeutic resistance remains the central obstacle in managing metastatic skin cancer. In ...

Immune checkpoint inhibitors (ICIs) have redefined the therapeutic landscape of oncology, producing durable responses across multiple tumor types and treatment settings. However, widespread adoption ...